These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11907157)

  • 1. New cytokine delivery system using gelatin microspheres containing interleukin-10 for experimental inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Ozeki M; Watanabe N; Ohana M; Uose S; Uchida K; Nishi T; Mastuura M; Tamaki H; Itoh T; Kawanami C; Chiba T
    J Pharmacol Exp Ther; 2002 Apr; 301(1):59-65. PubMed ID: 11907157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced macrophage responsiveness to lipopolysaccharide and CD40 stimulation in a murine model of inflammatory bowel disease: IL-10-deficient mice.
    Takakura R; Kiyohara T; Murayama Y; Miyazaki Y; Miyoshi Y; Shinomura Y; Matsuzawa Y
    Inflamm Res; 2002 Aug; 51(8):409-15. PubMed ID: 12234058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.
    Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL
    J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal drug delivery systems with biodegradable microspheres targeting mucosal immune-regulating cells for chronic inflammatory colitis.
    Okazaki K; Nakase H; Watanabe N; Tabata Y; Ikada Y; Chiba T
    J Gastroenterol; 2002 Nov; 37 Suppl 14():44-52. PubMed ID: 12572865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.
    Autenrieth IB; Bucheler N; Bohn E; Heinze G; Horak I
    Gut; 1997 Dec; 41(6):793-800. PubMed ID: 9462212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A20 ameliorates inflammatory bowel disease in mice via inhibiting NF-κB and STAT3 activation.
    Lee SH; Lee HR; Kwon JY; Jung K; Kim SY; Cho KH; Choi J; Lee HH; Lee BI; Jue DM; Cho ML
    Immunol Lett; 2018 Jun; 198():44-51. PubMed ID: 29608924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an oral drug delivery system targeting immune-regulating cells in experimental inflammatory bowel disease: a new therapeutic strategy.
    Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Matsushima Y; Kawanami C; Oshima C; Ikada Y; Chiba T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):15-21. PubMed ID: 10604927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease.
    Bhavsar MD; Amiji MM
    Gene Ther; 2008 Sep; 15(17):1200-9. PubMed ID: 18418416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of cytokine production in the colon of nude mice with experimental colitis induced by adoptive transfer of immunocompetent cells from mice infected with a murine retrovirus.
    Suriki H; Suzuki K; Baba Y; Hasegawa K; Narisawa R; Okada Y; Mizuochi T; Kawachi H; Shimizu F; Asakura H
    Clin Immunol; 2000 Oct; 97(1):33-42. PubMed ID: 10998315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production.
    Nakagawa T; Katsuno T; Noguchi Y; Mandai Y; Yoshihama S; Saito K; Maruoka D; Matsumura T; Arai M; Yokosuka O
    Biol Pharm Bull; 2015; 38(11):1681-8. PubMed ID: 26521820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sinomenine enteric-coated microspheres suppressed the TLR/NF-κB signaling in DSS-induced experimental colitis.
    Xiong H; Tian L; Zhao Z; Chen S; Zhao Q; Hong J; Xie Y; Zhou N; Fu Y
    Int Immunopharmacol; 2017 Sep; 50():251-262. PubMed ID: 28711031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.
    Fujimoto Y; Azuma YT; Matsuo Y; Kuwamura M; Kuramoto N; Miki M; Azuma N; Teramoto M; Nishiyama K; Izawa T; Nakajima H; Takeuchi T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):261-268. PubMed ID: 27942772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
    Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
    J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
    Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein.
    Nguyen DD; Maillard MH; Cotta-de-Almeida V; Mizoguchi E; Klein C; Fuss I; Nagler C; Mizoguchi A; Bhan AK; Snapper SB
    Gastroenterology; 2007 Oct; 133(4):1188-97. PubMed ID: 17764675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
    Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
    World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.
    Burich A; Hershberg R; Waggie K; Zeng W; Brabb T; Westrich G; Viney JL; Maggio-Price L
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G764-78. PubMed ID: 11518689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice.
    Watanabe N; Ikuta K; Okazaki K; Nakase H; Tabata Y; Matsuura M; Tamaki H; Kawanami C; Honjo T; Chiba T
    Dig Dis Sci; 2003 Feb; 48(2):408-14. PubMed ID: 12643623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.